Screener
Tectonic Therapeutics TECX Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Tectonic Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212016
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating expenses: | ||
| Research and development | $20,871 | $13,036 |
| General and administrative | 6,430 | 5,262 |
| Total operating expenses | 27,301 | 18,298 |
| Loss from operations | (27,301) | (18,298) |
| Other income (expense): | ||
| Interest income | 2,181 | 2,444 |
| Interest expense | (8) | (20) |
Item 1. Financial Statements.
FAQ
- What is Tectonic Therapeutics's total operating expenses?
- Tectonic Therapeutics (TECX) reported total operating expenses of $27.3M in Q1 2026.
- How has Tectonic Therapeutics's total operating expenses changed year-over-year?
- Tectonic Therapeutics's total operating expenses increased by 49.2% year-over-year, from $18.3M to $27.3M.
- What is the long-term trend for Tectonic Therapeutics's total operating expenses?
- Over 4 years (2021 to 2025), Tectonic Therapeutics's total operating expenses has grown at a -8.3% compound annual growth rate (CAGR), from $118.84M to $84.04M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about Tectonic Therapeutics's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude